ProCE Banner Activity

Expert View on CAR T-Cell Therapy: Delving Into Evolving Topics, Critical Aspects of Management, and Practice-Changing Data

Slideset Download
Review expert insights on incorporating CAR T-cell therapies into management of hematologic malignancies, including optimization of real-world patients, multidisciplinary management of toxicities, patient and caregiver education, and emerging data on the most promising investigational strategies.

Released: March 24, 2020

Expiration: March 23, 2021

No longer available for credit.

Share

Faculty

Matthew J. Frigault

Matthew J. Frigault, MD

Instructor of Medicine
Division of Oncology
Department of Internal Medicine
Harvard Medical School
Clinical Assistant
Hematopoietic Cell Transplant and Cellular Therapy Program
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Celgene

Gilead

Faculty Disclosure

Primary Author

Matthew J. Frigault, MD

Instructor of Medicine
Division of Oncology
Department of Internal Medicine
Harvard Medical School
Clinical Assistant
Hematopoietic Cell Transplant and Cellular Therapy Program
Massachusetts General Hospital Cancer Center
Boston, Massachusetts